Company: ACBM
Filing Date: 2025-07-18
Form Type: 10-K
Source: 0001640334-25-001245
Chunk: 510

Company: ACRO BIOMEDICAL CO., LTD.
Filing Date: 2025-07-18
Form: 10-K
Item: Item 8
Chunk 510
---
 Prepaid expenses  1,250   1,185 Total Current Assets  1,626   657,537          Operating lease right of use asset  52,233   25,719 Security deposit  4,600   4,230 TOTAL ASSETS $58,459  $687,486          LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)                 Current Liabilities        Accounts payable and accrued expenses $154,444  $76,571 Deferred revenue  20,000   20,000 Due to related parties  88,796   78,826 Operating lease liabilities - current  25,335   25,719 Total Current Liabilities  288,575   201,116          Operating lease liabilities - noncurrent  26,898   - TOTAL LIABILITIES  315,473   201,116          Stockholders' Equity (Deficit)        Preferred stock: 25,000,000 authorized; $0.001 par value; no shares issued and outstanding  -   - Common stock: 100,000,000 authorized; $0.001 par value; 60,042,000 shares issued and outstanding as of December 31, 2023 and 2022  60,042   60,042 Additional paid-in capital  32,298,442   32,295,236 Deferred stock compensation  -   (8,060,983)Accumulated deficit  (32,615,498)  (23,807,925)Total Stockholders’ (Deficit) Equity   (257,014)  486,370          TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) $58,459  $687,486 

The accompanying notes are an integral part of these financial statements.

 F-4Table of Contents

ACRO BIOMEDICAL CO., LTD.

Statements of Operations

  Year Ended   December 31,   2023  2022        Revenues $-  $658,500 Cost of revenues  -   518,000 Gross profit  -   140,500          Operating expenses